November 23, 2014 3:17 PM ET

Pharmaceuticals

Company Overview of Ascenta Therapeutics, Inc.

Executive Profile

Mel Sorensen M.D.

Chief Executive Officer, President, Director and Chairman of Ascenta Shanghai R&D Center, Ascenta Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
57--

Background

Dr. Mel Sorensen, M.D. serves as the Chief Executive Officer and President of Galera Therapeutics, Inc. Dr. Sorensen served as the Chief Executive Officer and President of Ascenta Therapeutics Inc., since joining in August 2004. He is a highly experienced leader and administrator in cancer therapeutics and cancer drug development. Trained as a medical oncologist, he has dedicated his career to clinical cancer research and cancer drug development. He spent seven years ...

Corporate Headquarters

101 Lindenwood Drive
Malvern, Pennsylvania 19355

United States

Phone: 610-408-0301
Fax: 610-725-1515

Board Members Memberships

Chief Executive Officer, President, Director and Chairman of Ascenta Shanghai R&D Center
Chief Executive Officer, President and Director
Chairman
2008-N/A
Former Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ascenta Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.